Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II romidepsin in relapsed or progressive peripheral T-cell lymphoma
2006-006228-21Phase 2Completed
- Sponsor
- Gloucester Pharmaceuticals
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of romidepsin in peripheral T-cell lymphoma (PTCL), sponsored by Gloucester Pharmaceuticals. Primary endpoint: Complete response rate. Started Jan 2007; status: completed.
02
Drugs
romidepsin
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on 2006-006228-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006228-21.